HEP-1
Also known as: Hepatocyte Peptide-1, Peptídeo Hepatocitário-1
Molecular Identifiers
Overview
Hepatocyte-derived peptide with hepatoprotective and regenerative properties. Designed to stimulate hepatocyte proliferation and support liver regeneration. In research phase as a potential therapeutic agent for chronic liver diseases and hepatocellular injury.
Research peptide — precise sequence not widely published in the literature
Half-life
~1-3 hours
Administration Route
Subcutaneous
Category
Specialized Research
Mechanism of Action
- Stimulation of hepatocyte proliferation via hepatic growth factors
- Support for liver regeneration after tissue injury
- Hepatocellular protection against oxidative stress
- Modulation of signaling pathways involved in liver repair
- Anti-apoptotic effect on damaged hepatocytes
Dosage Protocol
Data compiled from the literature. This does not constitute medical advice.
| Parameter | Value |
|---|---|
| Dose | 1-2 mg per injection (subcutaneous) |
| Frequency | Once daily |
| Timing | Morning or per clinical guidance |
| Duration | 2-4 weeks |
Reported Side Effects
Adverse effects described in the literature. Severity and frequency vary between individuals.
- Injection site pain
- Mild abdominal discomfort
Presentations & Preparation
Vials of HEP-1 found in the research market:
Reconstitution
- Diluent: Bacteriostatic water
- Volume: 1-2 ml per vial
- Inject the diluent slowly against the vial wall
- Gently swirl until fully dissolved — never shake
- Wait for complete dissolution before use
Storage
- Lyophilized: Refrigerated 2-8°C
- Reconstituted: Refrigerated 2-8°C (up to 14 days)
- Protect from direct light
- Do not freeze after reconstitution
- Limited stability — prepare close to time of use
Related Peptides
Aviptadil
50-150 mcg per administration (IV or subcutaneous) · 1-3 times daily per protocol
B7-33
100-500 mcg per injection (subcutaneous) · Once daily
Bronchogen
5-10 mg per day via subcutaneous injection · Once daily
Cardiogen
5-10 mg per day subcutaneously · Once daily
Chonluten
5-10 mg per day subcutaneously · Once daily
Crystagen
5-10 mg per day via subcutaneous injection · Once daily